XPOF

Xponential Fitness, Inc.

48
Fundamentals51/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential49/ 100

XPOF lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

XPOF Fundamentals

MetricStatus
Healthy
Stable
Weak
Weak

XPOF's revenue is currently healthy, and its profitability is stable, but its cash flow and balance sheet are weak.

XPOF PE Valuation

XPOF has no meaningful PE right now: it lost money over the past year.

XPOF Forward outlook

MetricOutlook
--
Strong growth
Stable
Strongly improving
Limited
Low

Analysts expect XPOF's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.

XPOF Risk to reward

ScenarioChangePrice
Upside+97%$9.13
Downside-49%$2.35

Calculated from the latest close: $4.63 on Nov 12.

XPOF's one-year upside scenario is about twice its downside: +97% against −49%.

XPOF Earnings Per Share

Q3 2024: $-1.15Q4 2024: $-2.27Q1 2025: $-2.07Q2 2025: $-1.79Q3 2025: $-1.68Q4 2025: $-1.47Q1 2026: $-1.39Q2 2026: $-1.48Q3 2026: $-1.20Forward: $0.49
Q3 2024: $-1.15Q4 2024: $-2.27Q1 2025: $-2.07Q2 2025: $-1.79Q3 2025: $-1.68Q4 2025: $-1.47Q1 2026: $-1.39Q2 2026: $-1.48Q3 2026: $-1.20Forward: $0.49
QuarterTTM EPSYoY
Forward$0.49—
Q3 2026-$1.20+$0.48
Q2 2026-$1.48+$0.31
Q1 2026-$1.39+$0.68
Q4 2025-$1.47+$0.80
Q3 2025-$1.68-$0.53

XPOF is still losing money, but less than at its worst: $1.20 per share over the past year, against $2.27 at its worst in late 2024.

XPOF Quarterly Revenue

Q4 2023: $3MQ1 2024: $3MQ2 2024: $4MQ3 2024: $4MQ4 2024: $4MQ1 2025: $3MQ2 2025: $3MQ3 2025: $2MQ4 2025: $3MQ1 2026: $2MQ2 2026: $3MQ3 2026: $3M
Q4 2023: $3MQ1 2024: $3MQ2 2024: $4MQ3 2024: $4MQ4 2024: $4MQ1 2025: $3MQ2 2025: $3MQ3 2025: $2MQ4 2025: $3MQ1 2026: $2MQ2 2026: $3MQ3 2026: $3M
QuarterRevenueYoY
Q3 2026$2.9M+23%
Q2 2026$2.7M-1%
Q1 2026$2.2M-17%
Q4 2025$3.4M-7.3%
Q3 2025$2.4M-37%
Q2 2025$2.7M-22%
Q1 2025$2.6M-14%
Q4 2024$3.6M+18%

XPOF's revenue is recovering but still below its 2022 peak: $3M last quarter, up 23% from the same quarter a year ago.

XPOF Free Cash Flow

Q4 2023: −$4MQ1 2024: $2MQ2 2024: $872,000Q3 2024: $3MQ4 2024: $864,000Q1 2025: $5MQ2 2025: $996,000Q3 2025: $8MQ4 2025: $10MQ1 2026: −$22MQ2 2026: −$4MQ3 2026: $4M
Q4 2023: −$4MQ1 2024: $2MQ2 2024: $872,000Q3 2024: $3MQ4 2024: $864,000Q1 2025: $5MQ2 2025: $996,000Q3 2025: $8MQ4 2025: $10MQ1 2026: −$22MQ2 2026: −$4MQ3 2026: $4M
QuarterFree cash flowYoY
Q3 2026$4.1M-50%
Q2 2026-$4.3M-533%
Q1 2026-$22.2M-514%
Q4 2025$10.2M+1077%
Q3 2025$8.2M+143%
Q2 2025$996K+14%
Q1 2025$5.4M+191%
Q4 2024$864K+$4.9M

XPOF's free cash flow has turned negative after years in the green: −$12M over the past year.

XPOF Total Shares

Q4 2023: 40MQ1 2024: 31MQ2 2024: 32MQ3 2024: 32MQ4 2024: 32MQ1 2025: 34MQ2 2025: 35MQ3 2025: 35MQ4 2025: 35MQ1 2026: 37MQ2 2026: 42MQ3 2026: 49M
Q4 2023: 40MQ1 2024: 31MQ2 2024: 32MQ3 2024: 32MQ4 2024: 32MQ1 2025: 34MQ2 2025: 35MQ3 2025: 35MQ4 2025: 35MQ1 2026: 37MQ2 2026: 42MQ3 2026: 49M
PeriodChange %Net change
Quarterly+17%+7.2M shares
1 year+40%+14.2M shares
3 years+60%+18.5M shares

XPOF has 49M diluted shares, up 40% from a year ago.

XPOF Net Leverage

Q4 2023: 5.1xQ1 2024: 4.2xQ2 2024: 9.1xQ3 2024: 16.4xQ4 2025: 14.4xQ1 2026: 14.0xQ2 2026: 17.1xQ3 2026: 11.5x
Q4 2023: 5.1xQ1 2024: 4.2xQ2 2024: 9.1xQ3 2024: 16.4xQ4 2025: 14.4xQ1 2026: 14.0xQ2 2026: 17.1xQ3 2026: 11.5x
QuarterNet LeverageStatus
Q3 202611.5xHigh
Q2 202617.1xHigh
Q1 202614.0xHigh
Q4 202514.4xHigh
Q3 202416.4xHigh
Q2 20249.1xHigh
Q1 20244.2xHigh
Q4 20235.1xHigh

XPOF's net debt is about 11 years of its operating earnings (EBITDA), down from 16 years a year ago.

XPOF Weekly Momentum

MetricValueStatus
RSI44.2Neutral
Stochastic35.7Neutral

XPOF's weekly RSI is 44 (neutral) and its Stochastic is 36 (neutral).

XPOF PE vs Consumer Cyclical Sector

XPOF has no meaningful PE right now: it lost money over the past year.

XPOF Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.502.9% above
20 week MA$5.119.4% below
50 week MA$6.1725% below
100 week MA$8.0042% below
200 week MA$12.864% below

XPOF has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 64% below its 200-week average.

XPOF Yearly ROI

YearStart priceEnd priceROI
2021$12.3$20.6+68%
2022$20.6$22.9+11%
2023$22.9$12.9-44%
2024$12.9$12.8-0.4%
2025$12.8$8.74-32%
2026 YTD$8.74$4.63-47%

XPOF has finished three years in a row lower, and it's down 47% so far in 2026.

Give your agent the market.

Get API key